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In endemic regions, visceral leishmaniasis is one of the most common opportunistic infections in HIV positive 
patients. Simultaneous infection with Leishmania and HIV has been reported in some countries but this is the first 
report of such a case in Iran. Our patient was a 27 years old man with intermittent night fever, abdominal pain, 
loss of appetite, vomiting, watery diarrhea and severe weight loss for 6 months. He had low socio-economic 
status with an imprisonment history. The patient was quite cachectic and had low grade fever. Physical exam 
and upper GI endoscopy revealed oropharyngeal candidiasis. Microscopic evaluation of duodenal biopsy materi-
al showed Leishmania amastigotes in macrophages of lamina propria. Leishman bodies were also observed in 
bone marrow aspiration specimen. Serologic tests were positive for Leishmania infantum. HIV antibody was also 
positive with a CD4
+cell count of 80/µl. The diagnosis was acquired immunodeficiency syndrome with simultane-
ous visceral leishmaniasis involving intestinal mucosa. 





Leishmaniasis is a disease of the reticuloendothelial 
system caused by kinetoplastid protozoa of the genus 
Leishmania.  All species that infect humans have an-
imal reservoirs and are transmitted by sand flies be-
longing to the genera Phlebotomus in the Old world 
and Lutzomia in the new world. The parasite assumes 
the amastigote form in mammalian host and the pro-
mastigote in insects. 
Leishmaniasis has different clinical forms. Viscer-
al, cutaneous and mucocutaneous forms are the best 
known ones. The form and severity of disease vary 
with the infecting  species,  the particular host’s  im-
mune status and prior exposure. 
Visceral leishmaniasis of the Old world is caused by 
L. donovani or by L. infantum. The infection usually is 
benign and often subclinical, although some individuals, 
especially  young  children  and  malnourished  patients, 
have marked involvement of the viscera, especially liv-
er, spleen, bone marrow, and lymph nodes.
1-3 Visceral 
leishmaniasis also is an opportunistic infection in indi-
viduals with concurrent human immunodeficiency virus 
(HIV)  disease,  and  the  condition  responds  poorly  to 






Our patient was a 27 years old man with intermittent 
nocturnal fever, abdominal pain, loss of appetite, vom-
iting, diarrhea and severe weight loss for 6  months. 
Patient was unemployed and had low socio-economic 
status. He had previous history of opioid use in forms 
of inhalation and digestion. He had been imprisoned 4 
years ago. He denied alcohol drinking and any unsafe 
sexual contact or intravenous drug use.  
The patient was quite cachectic and had low grade 
fever. Other vital signs were normal. Physical exam re-
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and  no  organomegaly  was  found.  The  results  of  his 
blood tests are depicted in Table1. Upper GI endoscopy 
revealed severe esophagitis due to Candida with scat-
tered whitish plaques on an erythematous basis. There 
were generalized nodularity and candidiasis lesions in 
duodenum. Microscopic evaluation of duodenal biopsy 
material showed partial blunting of the villi. Abundant 
macrophages  containing  intracytoplasmic  microorgan-
isms  had  infiltrated  and  expanded  the  lamina  propria. 
High  magnification  view  revealed  Leishmania 
amastigotes with nuclei and kinetoplasts (Figure 1 and 2). 
Leishman  bodies  were  also  observed  in  bone  marrow 
aspiration specimen (Figure 3). Budding yeast cells and 
pseudohyphae  of  Candida  albicans  were  also  seen  in 
duodenal mucosa (Figure 4). 
 
Table 1: Laboratory tests of the patients 
5.2  WBC( thous/mcl) 
82  PMN (%) 
15  Lymphocyte(%) 
11.5  Hemoglobin (g/dl) 
82  MCV (fl) 
240  Platelet COUNT( thous/mcl) 
24  BUN (mg/dl) 
0.9  Creatinin (mg/dl) 
24  AST (U/L) 
18  ALT (U/L) 
224  ALK-P (U/L) 
2.3  Albumin( g/dl) 
1.2  Bilirubin-T (mg/dl) 
0.3  Bilirubin-D (mg/dl) 
75  FBS   (mg/dl) 
138  Sodium (mEq/L) 
3.2  Pottasium (mEq/L) 
32  ESR (mm/hr) 
342  LDH (U/L) 
2+  CRP (mg/L) 
 
  
Fig. 1: Duodenal mucosa (haematoxylin and eosine, 
x 400) 
 
Fig.  2:  Macrophages  containing  Leishmania 








Fig. 4: The yeast and pseudohyphae of Candida albi-
cans (periodic acid-schiff, x400) Molaei et al. 
 
WWW.ircmj.com Vol 13 May 2011  350 
For definite diagnosis, we checked anti-leishman 
antibodies in the patient’s serum. Latex aglutination 
test  and  immunofluorescent  antibody  were  positive 
for Leishmania infantum. 
Because of poor general condition, generalized can-
didiasis  lesions  and  severe  cachexia  and  lymphopenia, 
patient was suspicious for HIV infection. HIV-Ab was 
positive with CD4+ cell count of 80/µl, hence diagnosis 
of AIDS with visceral leichmaniasis was confirmed.  
Patient  was  sent  to  the  special  center  for  AIDS 
treatment to receive the optimum care and unfortu-





In endemic areas, visceral leishmaniasis is one of the 
most common opportunistic infection in HIV positive 
patients. Concurrent HIV infection and leishmaniasis is 
reported in 33 countries;
5 but this is the first report of 
such a case in Iran. However there have been cases of 
intestinal leishmaniasis without HIV infection in Iran.
6  
Most cases of HIV negative patients with visceral 
leishmaniasis  are  infants.  But  AIDS  occurrence  has 
changed age prevalence and clinical features of the dis-
ease. It has been suggested that Leishmania could be 
transmitted from human to human through needle shar-
ing in IV drug abusers. Eighty percent of HIV positive 
patients  with  visceral  leishmaniasis  are  male.  More 
common high risk behavior and higher rate of IV drug 
abuse might be the reason of male predominance.
7 Most 
of HIV positive patients are affected by Leishmania in-
fantum or donovani; but the other species such as L. 
braziliensis, L. major and L. tropica have been reported 
in their geographical areas,
8 even though leishmaniasis 
in HIV positive patients has the clinical features of clas-
sic Kala-azar, cutaneous and muco-cutaneous leishman-
iasis in unusual sites are increasing. 
Leishmaniasis in patients who are HIV positive re-
veals diffuse visceral involvement and is not limited to 
the reticuloendothelial system. These patients respond 
slowly  to  treatment  and  their  relapse  rate  is  high.
9 
However atypical forms of leishmaniasis are seen in 
patients with normal immune system as well. In HIV-
co-infected patients, cytopenia is generally more com-
mon while organomegaly is seen less frequently.
10 In 
our  case,  visceral  leishmaniasis  was  not  associated 
with  organomegaly,  but  the  bone  marrow  was  in-
volved.  Gastrointestinal  involvement  is  relatively 
common in HIV positive individuals.
11 In fact, 3.2% of 
HIVpositive patients undergoing endoscopy for undi-
agnosed  digestive  symptoms  have  amastigotes.
12 
Leishmania  spp.  can  be accompanied  by  esophageal 
symptoms, epigastralgia, diarrhea, or rectal discomfort, 
although on occasion these symptoms are produced by 
other simultaneously infecting pathogens such as Cy-
tomegalovirus or Candida spp.
13-16 
It can invade any part of the digestive tract asymp-
tomatically; hence multiple random biopsies are indi-
cated in spite of normal looking mucosa.
17 The poly-
parasitic nature of Leishmania in AIDS makes it possi-
ble to detect its amastigotes and antigen in serum. Se-
rodiagnostic tests are not very useful in these patients. 
Positive response is related to the CD4 positive lym-
phocytes count and is seen in only 40-50% of cases. 
Level  of  anti-leishman  antibody  in  immunocompro-
mised patients is 50 times lower than those with nor-
mal immune system. Western blot and PCR are also 
accurate  diagnostic  tools  which  are  truly  accurate  if 
used with ELISA and DAT. In vitro cultivation is the 
gold standard diagnostic method.
9 Organic pentavalent 
antimonials are one of the mainstays of treatment for 
visceral  leishmaniasis;  although  patients  co-infected 
with  HIV  have  a  poor  response  to  this  therapy  and 
show a higher rate of serious side effects.
18,19  
In  conclusion,  visceral  leishmaniasis  should  be 
considered in the differential diagnosis of gastrointes-
tinal symptoms in HIV positive patients; especially in 
endemic countries and with a special attention to the 
impact of co-infection. 
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